Secondments




​​

Jaroslav JURACEK

FROM:  CEITEC Masaryk University, Czech Republic
TO:MDACC, University of Texas, USA

Jaroslav Juracek is currently postdoc in Ondrej Slaby Research Group at Central European Institute of Technology, Masaryk University (CEITEC, MU), Brno, CZ. He earned his Ph.D. in Oncology at Masaryk University, Brno, CZ. In his work he is focused mainly on circulating urinary non-coding RNAs in urologic malignancies and their clinical relevance.​

​​

Leonie OTT

FROM:  Universitätsklinikum Hamburg-Eppendorf, Germany
TO:MDACC, University of Texas, USA

Leonie Ott is a doctoral candidate in Sabine Riethdorfs´ working group at the Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Germany. She did her Bachelor and Master degree in „Molecular Life Sciences“ at the University of Hamburg. In her doctoral thesis she is focussing mainly on the detection and analysis of miRNAs in circulating tumor cells (CTCs) in breast cancer.​

Dominic BARTH

FROM:  Universitätsklinikum Hamburg-Eppendorf, Germany
TO:MDACC, University of Texas, USA

Dominik Barth has earned his MD degree at the Medical University of Graz, Austria. He is currently enrolled in PhD program at the same institution were he also started his clinical training in medical oncology. His main focus is on urogenital malignancies in clinical and biomarker research. 

​​

Rareș Constantin DRULA

FROM:  Iuliu Hatieganu University of Medicine and Pharmacy, Romania
TO:MDACC, University of Texas, USA

Rares Drula earned his bachelor and masters degrees from the Babes-Bolyai University of Cluj-Napoca and currently pursues a PhD in Medicine at the Iuliu Hatieganu University of Cluj-Napoca under the guidance of Prof. Ioana Neagoe and her research group at the university's Research Center of Functional Genomics, Biomedicine and Translational Medicine. His research is focused on the roles of circular RNAs in conjunction with other non-coding RNAs in lung cancer."


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 824036.
Disclaimer: This website and included materials reflect only the author’s view and the Research Executive Agency is not responsible for any use that may be made of the information it contains.